MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits

MPR Drug News

Younger Women Experience Less Pain Relief With Opioids - But Why?

A new study in the Journal of Women's Health has found that younger women are less likely to experience pain relief with long-term use of opioids for chronic non-cancer pain compared to men of the same age.

Drug Used to Reduce Mortality After MI Discontinued, Generic in Shortage

Lopressor (metoprolol tartrate) 1mg/1mL solution for IV injection has been discontinued by Novartis Pharmaceuticals. The decision to discontinue the product is business-related and not based on efficacy or safety findings.

Carotenoids in Fruits, Vegetables May Lower Risk of Advanced AMD

A greater intake of bioavailable carotenoids, particularly lutein/zeaxanthin and beta-carotene, has been linked to a reduced risk of advanced age-related macular degeneration (AMD) based on two prospective cohort studies. The research appears in JAMA Ophthalmology.

New Drug for Tardive Dyskinesia Demonstrates Efficacy in Phase 3 Study

Neurocrine Biosciences announced positive results from its Kinect 3 study, showing that NBI-98854 achieved a statistically significant reduction in tardive dyskinesia during the 6 weeks of treatment in patients with underlying schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder.

Potentially Problematic Drugs for the Elderly: Beers Criteria Updated

The American Geriatrics Society (AFS) has released its second updated and expanded Beers Criteria, including alternative therapies for potentially inappropriate medications and more detailed guidance on best practices for implementing AGS recommendations.